Document Detail


A new insight into mushroom tyrosinase inhibitors: docking, pharmacophore-based virtual screening, and molecular modeling studies.
MedLine Citation:
PMID:  24601849     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Tyrosinase, a widely spread enzyme in micro-organisms, animals, and plants, participates in two rate-limiting steps in melanin formation pathway which is responsible for skin protection against UV lights' harm whose functional deficiency result in serious dermatological diseases. This enzyme seems to be responsible for neuromelanin formation in human brain as well. In plants, the enzyme leads the browning pathway which is commonly observed in injured tissues that is economically very unfavorable. Among different types of tyrosinase, mushroom tyrosinase has the highest homology with the mammalian tyrosinase and the only commercial tyrosinase available. In this study, ligand-based pharmacophore drug discovery method was applied to rapidly identify mushroom tyrosinase enzyme inhibitors using virtual screening. The model pharmacophore of essential interactions was developed and refined studying already experimentally discovered potent inhibitors employing Docking analysis methodology. After pharmacophore virtual screening and binding modes prediction, 14 compounds from ZINC database were identified as potent inhibitors of mushroom tyrosinase which were classified into five groups according to their chemical structures. The inhibition behavior of the discovered compounds was further studied through Classical Molecular Dynamic Simulations and the conformational changes induced by the presence of the studied ligands were discussed and compared to those of the substrate, tyrosine. According to the obtained results, five novel leads are introduced to be further optimized or directly used as potent inhibitors of mushroom tyrosinase.
Authors:
Kowsar Bagherzadeh; Faezeh Shirgahi Talari; Amirhossein Sharifi; Mohammad Reza Ganjali; Ali Akbar Saboury; Massoud Amanlou
Related Documents :
23219719 - Förster resonance energy transfer competitive displacement assay for human soluble epox...
23594139 - Structure-based design, discovery and development of checkpoint kinase inhibitors as po...
24718729 - Structural elucidation of srta enzyme in enterococcus faecalis: an emphasis on screenin...
24724799 - Structure and catalytic regulatory function of ubiquitin specific protease 11 n-termina...
23911089 - Redox-linked domain movements in the catalytic cycle of cytochrome p450 reductase.
24018659 - Requirement of catalytic-triad and related amino acids for the acyltransferase activity...
11278909 - The crystal structure of the inhibitor-complexed carboxypeptidase d domain ii and the m...
20947159 - Synthesis and biological activities of a library of glycosaminoglycans mimetic oligosac...
19754039 - "zipper" molecular beacons: a generalized strategy to optimize the performance of activ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-3-6
Journal Detail:
Title:  Journal of biomolecular structure & dynamics     Volume:  -     ISSN:  1538-0254     ISO Abbreviation:  J. Biomol. Struct. Dyn.     Publication Date:  2014 Mar 
Date Detail:
Created Date:  2014-3-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8404176     Medline TA:  J Biomol Struct Dyn     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Do Insulin Resistance Conditions Further Impair the Lipid and Inflammatory Profile in End-Stage Rena...
Next Document:  Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source ...